Medicine Online
Any medical inquiries? Search MOL for answers:
NEWS
Home > News > 2007 > February > 27 > Mouse Study Sheds Light on Lupus-Linked Depression
Medical References
Diseases & Conditions
Women's Health
Mental Health
Men's Health
Medical Web Links
MOL Site Map
Medical Tips
Attention, chocolate lovers: You may not be able to help yourselves. Swiss and British scientists have linked the widespread love of chocolate to a chemical "signature" that may be programmed into our metabolic systems.
Read more health news

Mouse Study Sheds Light on Lupus-Linked Depression

TUESDAY, Feb. 27 (HealthDay News) -- An auto-antibody called "anti-ribosomal P" plays a role in central nervous dysfunction and depression in people with lupus, an autoimmune disease that also causes symptoms such as joint pain, skin rashes and extreme fatigue.

Scientists at Tel Aviv University in Israel extracted anti-ribosomal P antibodies from the blood of a lupus patient and injected them into healthy mice.

The scientists noted the onset of depression-like behavior changes in the mice as the rodents were put through a swimming test.

The study also found that long-term treatment with fluoxetine (Prozac) resulted in a significant reduction in depression-like behavior in the mice.

The findings, which appear in the March issue of Arthritis & Rheumatism, shed light on brain pathways of depression in general and on central nervous system dysfunction in lupus in particular, the researchers said.

Further investigation needs to be conducted in large-scale clinical trials.

"Elucidating the mechanisms by which anti-ribosomal P induces behavioral changes may lead to novel therapeutic advances for [lupus] patients with depression," noted study author Dr. Yehuda Shoenfeld.

More information

The American Medical Association has more about lupus.



-- Robert Preidt



SOURCE: Arthritis & Rheumatism, news release, Feb. 27, 2007

Last Updated: Feb. 27, 2007

Copyright © 2007 ScoutNews, LLC. All rights reserved.

HomeSitemap Contact UsAdvertisingPress RoomGive Us Your FeedbackRead Our Terms & Conditions and Our DisclaimerPrivacy Statement